Enter Your Email Address to Receive a
Copy of MedicExhange Member Demograhpics

Confirma, supplier of application-specific CAD for MRI, announced today that it has installed CADstream for prostate at research sites including MRI at Belfair, Beth Israel, Simonmed and Lahey Clinic. Confirma, supplier of application-specific CAD for MRI, announced today that it has installed CADstream for prostate at research sites including MRI at Belfair, Beth Israel, Simonmed and Lahey Clinic. These research sites are assisting Confirma in the development and commercialization of CADstream for prostate. The prostate application will offer physicians comprehensive and clinically valuable tools for improved quality, standardization and efficiency in MRI studies of the prostate. The Company recently exhibited at the National Conference on Prostate Cancer in Los Angeles and the AdMeTech Foundation Conference in Washington, DC with its research version of CADstream for prostate.

"As a research site, MRI at Belfair prides itself on utilizing the most advanced clinical imaging analysis tools." said Dr. Borelli. "CADstream for breast has already proven itself to be indispensable in our practice. Now, CADstream for prostate is showing great promise, allowing us to confidently map disease within the gland for minimally invasive treatment planning."

"Over the past five years, CADstream for breast MRI has received broad scale acceptance from the women's imaging community," said Wayne Wager, president and CEO, Confirma, Inc. "We believe that prostate research studies and ongoing development with our research sites will help establish CAD within the men's imaging community. CADstream for prostate MRI will improve the quality, standardization and efficiency of study analysis, interpretation and reporting. CAD provides physicians valuable tools to improve the detection of cancer and treatment planning.